Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
Type:
Application
Filed:
May 9, 2013
Publication date:
September 19, 2013
Applicants:
PURDUE PHARMACEUTICALS L.P., THE P.F. LABORATORIES, INC.
Inventors:
Curtis Wright, Benjamin Oshlack, Christopher Breder